Evidence map›Paper›PMID 38672528›Full record

ReviewCancers2024

Ovarian Causes of Pseudomyxoma Peritonei (PMP)-A Literature Review.

Sinziana Ionescu, Marian Marincas, Octavia Luciana Madge, Irinel Gabriel Dicu-Andreescu, Elena Chitoran, Vlad Rotaru, Ciprian Cirimbei, Mirela Gherghe, Adina Ene, Robert Rosca and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Huge mucinous ovarian borderline tumor: a case report.Journal of surgical case reports · 2025
    Article
  7. Magnetic Hydrogels as a Treatment for Oncological Pathologies.Journal of functional biomaterials · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sinziana IonescuSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-0839-0651
Marian MarincasSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Octavia Luciana MadgeGeneral Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology "Prof. Dr. Al. Trestioreanu", 022328 Bucharest, Romania.
Irinel Gabriel Dicu-AndreescuGeneral Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology "Prof. Dr. Al. Trestioreanu", 022328 Bucharest, Romania.
Elena ChitoranSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0001-9225-8030
Vlad RotaruSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Ciprian CirimbeiSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Mirela GhergheSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Adina EnePathology Department, Oncological Institute "Prof. Dr. Alexandru Trestioreanu", 022328 Bucharest, Romania.
Robert RoscaPathology Department, Bucharest Emergency University Hospital, 050098 Bucharest, Romania.
Madalina RaduPathology Department, Oncological Institute "Prof. Dr. Alexandru Trestioreanu", 022328 Bucharest, Romania.
Laurentiu SimionSurgery Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROInstitutul Oncologic Bucuresti · ROClinical Emergency Hospital Bucharest · ROUniversity of Bucharest · RO

Funding

Program "Publish, Not Perish" from "Carol Davila" University of Medicine and Pharmacy, from Bucharest, Romania Program "Publish, Not Perish" from "Carol Davila" University of Medicine and Pharmacy, from Bucharest, Romania
6 · The paper itself

Abstract

backgroundPseudomyxoma peritonei (PMP) is a rare, progressive, slowly growing, inadequately understood neoplasm with a 5-year progression-free survival rate of as low as 48%. It is characterized by varying degrees of malignancy and the production of mucinous and gelatinous structures. Typically, the development of pseudomyxoma peritonei is associated with the rupture of appendiceal mucinous tumors and other gastrointestinal or ovarian mucinous tumors. The goal of our literature review was to identify various aspects that characterize the ovarian causes of pseudomyxoma peritonei. MATERIALS AND

methodsThe authors performed an extensive literature search between 1 February 2024 and 2 March 2024 on the following databases: Pubmed, Scopus, Oxford Journals, and Reaxys, and the findings were summarized into seven main clinical and paraclinical situations.

resultsAccording to our research, the main instances in which pseudomyxoma peritonei can be triggered by an ovarian cause are the following: (1) mucinous cystadenoma; (2) mucinous ovarian cancer; (3) colon cancer with ovarian metastasis; (4) malignant transformation of an ovarian primary mature cystic teratoma; (5) appendiceal mucocele with peritoneal dissemination mimicking an ovarian tumor with peritoneal carcinomatosis; (6) mucinous borderline tumor developing inside an ovarian teratoma; and (7) the association between a mucinous bilateral ovarian cancer and a colonic tumor.

conclusionsIn our study, we aimed to provide a comprehensive overview of the ovarian causes of pseudomyxoma peritonei, including its epidemiology, imagery characteristics, symptoms, current treatment, and promising future therapies, in the hopes of finding feasible solutions, as a lack of understanding of this mucus-secreting malignant disease increases the risk of delayed diagnosis or uncontrolled deterioration.

Indexed as

cancergelatinous diseasegynecologymucinous diseaseoncologyovarian cancerperitoneal metastasispseudomyxoma peritoneisurgerysurgical oncology

Identifiers

PMID38672528
PMCPMC11047873
OpenAlexW4394621657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.